Freedom Capital Markets maintains Buy rating on Inspire Medical Systems

Freedom Capital Markets maintained its Buy rating on Inspire Medical Systems's stock with a price target of $97.00. The price target implies an upside of 37.0% from the Oct 1 close of $70.78. Key takeaways from the analyst note included the approval of new CPT codes for the company's procedures.